LGALS9 and glioblastoma: LGALS9, a specific protein cargo contained in Glioblastoma-CSF-EVs, was shown to inhibit the antigen presentation of dendritic cells and cytotoxic T cell (CD8+) immunity, promoting tumor progression [85].